CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...

In other recent news, Cigna Corporation reported strong first-quarter 2025 earnings, with an adjusted earnings per share (EPS) of $6.74, surpassing the consensus estimate of $6.35.

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...

As Trump's sweeping tax-cut and spending bill marches forward, analysts examine how his broad-ranging policies could turn the ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an analysis of HIMS stock now.